Pharmacologically, losartan normalized the glycemia and insulin changes due to obesity, but OBL sustained superior HOMA values and impaired insulin sensitivity, as seen by ITT's AUC in relation to CL. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.